Search hospitals
>
Missouri
>
Cape Girardeau
Saint Francis Medical Center
Claim this profile
Cape Girardeau, Missouri 63703
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
430 reported clinical trials
5 medical researchers
Summary
Saint Francis Medical Center is a medical facility located in Cape Girardeau, Missouri. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Francis Medical Center is involved with conducting 430 clinical trials across 471 conditions. There are 5 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Robert H. Stone, RRT, and Stephen S. Bricknell, RRT.
Area of expertise
Cancer
Saint Francis Medical Center has run 104 trials for Cancer. Some of their research focus areas include:
Lung Cancer
Saint Francis Medical Center has run 75 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Bryan A. Faller
Crossroads Cancer Center
7 years of reported clinical research
James L. Wade
Decatur Memorial Hospital
5 years of reported clinical research
Robert H. Stone, RRT
Saint Francis Medical Center
17 years of reported clinical research
Stephen S. Bricknell, RRT
Saint Francis Medical Center
17 years of reported clinical research
Clinical Trials running at Saint Francis Medical Center
Bladder Cancer
Lung Cancer
Prostate Cancer
Cancer
Kidney Cancer
Breast cancer
Breast Cancer
Bladder Carcinoma
Non-Small Cell Lung Cancer
Ovarian Cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Pembrolizumab + Sacituzumab Govitecan
for Urothelial Cancer
This phase III trial compares the effectiveness of pembrolizumab and sacituzumab govitecan to standard of care in treating patients with urothelial cancer that has spread to nearby tissue or lymph nodes (locally advanced) or that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug called govitecan. Sacituzumab attaches to TROP2 positive tumor cells in a targeted way and delivers govitecan to kill them. The usual treatment approach is treatment with chemotherapy such as cisplatin, carboplatin, gemcitabine, docetaxel or paclitaxel. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making deoxyribonucleic acid and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Paclitaxel is in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Giving pembrolizumab and sacituzumab govitecan may be more effective than usual care of carboplatin or cisplatin with gemcitabine, docetaxel or paclitaxel in treating patients with locally advanced or metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
17 criteria
Shorter Duration Radiation Therapy
for Bladder Cancer
This phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypofractionation) with standard of care chemotherapy, with cisplatin, gemcitabine or mitomycin and 5-fluorouracil for the treatment of patients with muscle invasive bladder cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a short period of time. Ultra-hypofractionated radiation therapy delivers radiation over an even shorter period of time than hypofractionated radiation therapy. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Chemotherapy drugs, such as mitomycin-C and 5-fluorouracil (5-FU), work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ultra-hypofractionated radiation may be equally effective as hypofractionated therapy for patients with muscle invasive bladder cancer.
Recruiting
2 awards
Phase 3
7 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Francis Medical Center?
Saint Francis Medical Center is a medical facility located in Cape Girardeau, Missouri. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Francis Medical Center is involved with conducting 430 clinical trials across 471 conditions. There are 5 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Robert H. Stone, RRT, and Stephen S. Bricknell, RRT.
Where is Saint Francis Medical Center located?
**Saint Francis Medical Center** - **Address:** 211 Saint Francis Drive, Cape Girardeau, MO 63703. - **Directions:** - From Missouri: Take Interstate 55 to exit 96, then head east on William Street/Route K. - From Illinois: Take Highway 146 to Highway 74, then turn right onto Mt. Auburn Road.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Saint Francis Medical Center, contact Customer Service at 573-331-5217 or 1-866-304-3071 (Monday – Friday, 8:00 am – 5:30 pm), request assistance online, or visit the Saint Francis Business Office. For insurance inquiries, call the provided numbers or visit the business office during operating hours.
What insurance does Saint Francis Medical Center accept?
Saint Francis Medical Center accepts a broad spectrum of insurance plans, including commercial insurance plans like Aetna Health Incorporated, Anthem Blue Cross Blue Shield, Cigna Health Care, Coventry Health Care, and UnitedHealthcare. They also welcome Medicaid plans from Missouri, Illinois, and Kentucky, in addition to Medicare and Medicare Advantage plans. Patients are advised to verify coverage with their insurance carrier prior to receiving services and bring their insurance card to appointments for accurate billing.
What awards or recognition has Saint Francis Medical Center received?
Saint Francis Medical Center, located in Cape Girardeau, Missouri, is nationally recognized for its excellence in clinical trial enrollments via the National Cancer Institute's NCORP. The hospital is acclaimed for its major service lines: neurosciences, cardiovascular services, cancer services, orthopedic services, and radiology, highlighting its commitment to quality and innovation in healthcare.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.